Literature DB >> 27257826

Assessment of estrogenic and androgenic activity in PM10 air samples from an urban, industrial and rural area in Flanders (Belgium) using the CALUX bioassay.

Kim Croes1, Rosette Van den Heuvel2, Bo Van den Bril3, Jeroen Staelens3, Michael S Denison4, Kersten Van Langenhove5, Tara Vandermarken5, Marc Elskens5.   

Abstract

BACKGROUND: Endocrine disrupting chemicals represent a broad class of compounds, are widespread in the environment and can pose severe health effects.
OBJECTIVES: The objective of this study was to investigate and compare the overall estrogen and androgen activating potential of PM10 air samples at an urban, rural and industrial location in Flanders, using a human in vitro cell bioassay.
METHODS: PM10 samples were collected on glass fiber filters every six days between April 2013 and January 2014 using a high-volume sampler. Extraction was executed with a hexane/acetone mixture before analysis using a recombinant estrogen- or androgen responsive human carcinoma cell line. Results were expressed as bioanalytical equivalents (BEQs) per cubic meter of air.
RESULTS: High fluctuations in estrogenic activity were observed during the entire sampling period, with median BEQs of 32.1, 35.9 and 31.1 fg E2-Eq m(-)³ in the industrial, urban and rural background area, respectively. Estrogenic activity was measured in 70% of the samples, while no androgenic activity was observed in any of the samples. The estrogenic activity in the industrial area was positively correlated with the airborne concentration of the sum of the non-carcinogenic PAHs pyrene and fluoranthene (rho=0.48; p<0.01) and the sum of the carcinogenic PAHs (rho=0.36; p=0.05).
CONCLUSIONS: This study showed that no androgenic activity was present in PM10 and that although the median estrogenic activity was rather low and comparable in the three locations, high fluctuations in estrogenic response exist over time. While atmospheric PAHs contributed to the observed estrogenic response, especially in the industrial area, the chemicals responsible for the majority of estrogenic activity remain to be identified.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Androgen; Belgium; CALUX; EDC; Estrogen; PM(10)

Mesh:

Substances:

Year:  2016        PMID: 27257826      PMCID: PMC7932495          DOI: 10.1016/j.envres.2016.05.044

Source DB:  PubMed          Journal:  Environ Res        ISSN: 0013-9351            Impact factor:   6.498


  31 in total

1.  Wintertime spatio-temporal variation of ultrafine particles in a Belgian city.

Authors:  Vinit K Mishra; Prashant Kumar; Martine Van Poppel; Nico Bleux; Evelien Frijns; Matteo Reggente; Patrick Berghmans; Luc Int Panis; Roeland Samson
Journal:  Sci Total Environ       Date:  2012-06-14       Impact factor: 7.963

2.  Detection of multiple hormonal activities in wastewater effluents and surface water, using a panel of steroid receptor CALUX bioassays.

Authors:  Sander C Van der Linden; Minne B Heringa; Hai-Yen Man; Edwin Sonneveld; Leo M Puijker; Abraham Brouwer; Bart Van der Burg
Journal:  Environ Sci Technol       Date:  2008-08-01       Impact factor: 9.028

3.  Fate of selected estrogenic hormones in an urban sewage treatment plant in Tunisia (North Africa).

Authors:  Dalel Belhaj; Rim Baccar; Ikram Jaabiri; Jalel Bouzid; Moneem Kallel; Habib Ayadi; John L Zhou
Journal:  Sci Total Environ       Date:  2014-10-12       Impact factor: 7.963

4.  Methodology for profiling anti-androgen mixtures in river water using multiple passive samplers and bioassay-directed analyses.

Authors:  Camilla Liscio; Alaa Abdul-Sada; Raghad Al-Salhi; Michael H Ramsey; Elizabeth M Hill
Journal:  Water Res       Date:  2014-03-27       Impact factor: 11.236

5.  CALUX measurements: statistical inferences for the dose-response curve.

Authors:  M Elskens; D S Baston; C Stumpf; J Haedrich; I Keupers; K Croes; M S Denison; W Baeyens; L Goeyens
Journal:  Talanta       Date:  2011-07-18       Impact factor: 6.057

Review 6.  Characterisation and implementation of the ERE-CALUX bioassay on indoor dust samples of kindergartens to assess estrogenic potencies.

Authors:  T Vandermarken; S De Galan; K Croes; K Van Langenhove; J Vercammen; H Sanctorum; M S Denison; L Goeyens; M Elskens; W Baeyens
Journal:  J Steroid Biochem Mol Biol       Date:  2015-01-13       Impact factor: 4.292

7.  Analysis of the antiestrogenic activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in human ovarian carcinoma BG-1 cells.

Authors:  Jane M Rogers; Michael S Denison
Journal:  Mol Pharmacol       Date:  2002-06       Impact factor: 4.436

8.  Assessment of estrogenic activity in PM₁₀ air samples with the ERE-CALUX bioassay: Method optimization and implementation at an urban location in Flanders (Belgium).

Authors:  Kim Croes; Pieterjan Debaillie; Bo Van den Bril; Jeroen Staelens; Tara Vandermarken; Kersten Van Langenhove; Michael S Denison; Martine Leermakers; Marc Elskens
Journal:  Chemosphere       Date:  2015-09-15       Impact factor: 7.086

9.  Effects of polycyclic aromatic hydrocarbons (PAHs) in environmental pollution on exogenous and oxidative DNA damage (EXPAH project): description of the population under study.

Authors:  Emanuela Taioli; Radim J Sram; Seymour Garte; Ivan Kalina; Todor A Popov; Peter B Farmer
Journal:  Mutat Res       Date:  2007-03-03       Impact factor: 2.433

10.  Masking effect of anti-androgens on androgenic activity in European river sediment unveiled by effect-directed analysis.

Authors:  Jana M Weiss; Timo Hamers; Kevin V Thomas; Sander van der Linden; Pim E G Leonards; Marja H Lamoree
Journal:  Anal Bioanal Chem       Date:  2009-05-06       Impact factor: 4.142

View more
  1 in total

1.  Identifying Toxicologically Significant Compounds in Urban Wildfire Ash Using In Vitro Bioassays and High-Resolution Mass Spectrometry.

Authors:  Thomas M Young; Gabrielle P Black; Luann Wong; Clayton S Bloszies; Oliver Fiehn; Guochun He; Michael S Denison; Christoph F A Vogel; Blythe Durbin-Johnson
Journal:  Environ Sci Technol       Date:  2021-03-01       Impact factor: 9.028

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.